REPLReplimune Group, Inc.
14.77USD-0.27%Mkt Cap: 1.39B $P/E: —3d ago
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom. The company's prop…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.39B $
Enterprise Value1.24B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-313.94M $
Revenue/Share—
Last Price14.77 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees465
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS76029N1063
Valuation
P/E (Trailing)—
P/E (Forward)-11.64
PEG—
EV/EBITDA-4.27
EV/Revenue—
P/S—
P/B11.17
EPS (TTM)-2.99
EPS (Forward)-1.21
52W Range
1.50094% of range15.69
52W High15.69 USD
52W Low1.500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-188.94%
ROA-94.45%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-280.34M $
CapEx (TTM)4.22M $
FCF Margin—
FCF Yield-12.34%
Net Debt-83.35M $
Net Debt/EBITDA0.29
Balance Sheet
Debt/Equity0.67
Current Ratio5.23
Quick Ratio5.08
Book Value/Sh1.258 USD
Cash/Share2.073 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)19.33 USD
Upside (mean)+30.9%
Target Range14.00 USD – 24.00 USD
$14.00+30.9% to mean$24.00
# Analysts6
Ownership
Shares Out.94.22M
Float67.61M
Insiders1.70%
Institutions104.19%
Short Interest
Short Ratio4.7d
Short % Float57.95%
Short % Out.32.78%
Shares Short27.54M
Short (prev mo.)23.67M
Technical
SMA 5011.04 (+33.8%)
SMA 2008.233 (+79.4%)
Beta0.90
S&P 52W Chg18.16%
Avg Vol (30d)6.29M
Avg Vol (10d)5.01M
Technical Indicators
RSI (14)64.7
MACD1.3772
MACD Signal1.0878
MACD Hist.+0.2894
BB Upper17.88 USD
BB Middle11.95 USD
BB Lower6.019 USD
BB Width99.26%
ATR (14)1.432 USD
Vol Ratio (20d)0.37x